Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|February 23, 2023
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trialsBeatrice Noce, Elisabetta Di Bello, Rossella Fioravanti, et al.
Chimia|December 9, 2023
Current HDAC Inhibitors in Clinical TrialsElisabetta Di Bello, Beatrice Noce, Rossella Fioravanti, et al.
Frontiers in Chemistry|July 7, 2020
The Innovative Potential of Statins in Cancer: New Targets for New TherapiesElisabetta Di Bello, Clemens Zwergel, Antonello Mai, et al.
Molecules (Basel, Switzerland)|July 12, 2020
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer CellsRossella Fioravanti, Stefano Tomassi, Elisabetta Di Bello, et al.
Chemmedchem|November 21, 2020
Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer ActivityClemens Zwergel, Elisabetta Di Bello, Rossella Fioravanti, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 23, 2022
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activityRossella Fioravanti, Veronica Rodriguez, Jonatan Caroli, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer CellsAnnalisa Romanelli, Giulia Stazi, Rossella Fioravanti, et al.
ACS Infectious Diseases|June 22, 2022
Effects of Structurally Different HDAC Inhibitors against Trypanosoma cruzi, Leishmania, and Schistosoma mansoniElisabetta Di Bello, Beatrice Noce, Rossella Fioravanti, et al.
Chemmedchem|October 17, 2022
Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult StagesBeatrice Noce, Elisabetta Di Bello, Clemens Zwergel, et al.
Pageof 2